Literature DB >> 13234407

Myleran in chronic myeloid leukaemia.

D A GALTON, M TILL.   

Abstract

Entities:  

Keywords:  GLYCOLS/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy

Mesh：

Substances：

Year:  1955        PMID： 13234407     DOI： 10.1016/s0140-6736(55)90212-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  TRYPSIN in thrombo-embolic disease.

Authors: 
Journal:  Br Med J       Date:  1955-06-04

2.  [Long-term chemotherapy of chronic myeloid leukemia with Myleran and C69].

Authors:  H EHRHART
Journal:  Klin Wochenschr       Date:  1962-06-15

3.  [Studies on the problem of the genetic effectiveness of myleran on Drosophila melanogaster].

Authors:  G ROHRBORN
Journal:  Z Vererbungsl       Date:  1959

4.  Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Authors:  F G HAYHOE; D KOK
Journal:  Br Med J       Date:  1957-12-21

5.  Treatment of chronic myeloid leukaemia with mercaptopurine.

Authors:  J R FOUNTAIN
Journal:  Br Med J       Date:  1956-12-08

6.  CHEMOTHERAPY of cancer.

Authors: 
Journal:  Br Med J       Date:  1955-10-01

Review 7.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

8.  Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.

Authors:  Kaylind Batey; Jisoo Kim; Lauren Brinster; Gladys Gonzalez-Matias; Zhijie Wu; Sabrina Solorzano; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2021-11-08       Impact factor: 3.084

9.  Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase.

Authors:  L Schwarzenberg; G Mathé; P Pouillart; R Weiner; J Locour; J Genin; M Schneider; F De Vassal; M Hayat; J L Amiel; J R Schlumberger; C Jasmin; C Rosenfeld
Journal:  Br Med J       Date:  1973-03-24

10.  Desacetylmethylcolchicine in the treatment of myeloid leukaemia.

Authors:  A M JELLIFFE; J E MACIVER
Journal:  Br J Cancer       Date:  1956-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.